To understand the effects of exercise modalities on cytotoxic lymphocyte function in individuals with CFS/ME, this 12‐week pilot trial focused on NK cell degranulation markers LAMP‐1/LAMP‐2 and CD8+CD38+ expression following GE and IE, compared to normal care. The gene discussed is LAMP1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.